FDA introduces a new roadmap to reduce animal testing in monoclonal antibody development using AI models, organoid testing and real-world data to enhance safety and efficiency.
Latest Ratings for CERT
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Morgan Stanley | Maintains | Equal-Weight | |
| Mar 2022 | Barclays | Maintains | Overweight | |
| Jan 2022 | Jefferies | Upgrades | Hold | Buy |
